Author:
De Grijse J., ,Asanghanwa M.,Nouthe B.,Albrecher N.,Goubert P.,Vermeulen I.,Van Der Meeren S.,Decochez K.,Weets I.,Keymeulen B.,Lampasona V.,Wenzlau J.,Hutton J. C.,Pipeleers D.,Gorus F. K.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference32 articles.
1. Keymeulen B, Vandemeulebroucke E, Ziegler A et al (2005) Insulin needs following CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352:2598–2608
2. Vandemeulebroucke E, Keymeulen B, Decochez K et al (2009) Hyperglycaemic clamp test for diabetes risk assessment in IA-2 antibody-positive relatives of type 1 diabetic patients. Diabetologia. doi: 10.1007/s00125-009-1569-3
3. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 91:123–127
4. Gorus FK, Pipeleers DG (2001) Prospects for predicting and stopping the development of type 1 diabetes. Best Pract Res Clin Endocrinol 15:371–389
5. Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA 512bdc/IA-2 autoantibodies. Diabetes 45:926–933
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献